Sky View Investment Advisors, LLC Astrazeneca PLC Transaction History

Sky View Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$66.81 - $80.83 $4,877 - $5,900	73 Added 0.67%	10,992 $857,000
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $666,386 - $759,634	10,919 New	10,919 $740,000
Q3 2023 Nov 16, 2023	BUY	$64.85 - $71.7 $29,701 - $32,838	458 Added 5.66%	8,551 $579,000
Q2 2023 Aug 15, 2023	BUY	$69.91 - $75.81 $565,781 - $613,530	8,093 New	8,093 $579,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.